oral glutathione bioavailability liposomal randomized trial outperforms plain glutathione in uptake, cell regeneration and systemic availability: evidence from cellular and human models liposomal glutathione bioavailability study human

The present invention solves these problems by providing BPC peptide salts and a pharmaceutical or diagnostic composition comprising a pharmaceutically or diagnostically effective amount of the salts of BPC peptides said peptides being constituted of 8 to 15 amino acids, wherein the anion of the salt is a negatively charged peptide comprising 8 amino acid residues having the general formula (I) Yaa is a basic amino acid residue, in particular Lys, Arg, Orn or His and Zaa is an acidic amino acid residue, in particular Glu, Asp, Aad or Apm and wherein the cation of the salt is the cation of an inorganic or organic nontoxic and pharmaceutically acceptable base

What does this mean for patients

:

3 The proposed non-surgical therapeutic options are represented by: physical activity restriction, physio kinesitherapy and muscle strengthening exercises, load restriction (partial with crutches or total with wheelchair), immobilization (with brace or plaster) and instrumental physical therapies, particularly in patients nearing the end of growth (eg

What stood out immediately was their thorough, responsible approach